| Intrinsic Valuation of: ASTRAL | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 19 | Market Cap | ₹417B | |||||
| 2021 | - | - (-) | P/E Ratio | 83 | Total Asset | ₹51B | |||||
| 2022 | ₹2B | - (-) | Net Income | ₹5B | Total Debt | ₹898M | |||||
| 2023 | ₹2B | 24.8% (6.3%) | EBITDA | ₹10B | Total Liab | ₹14B | |||||
| 2024 | ₹3B | 9.6% (0.2%) | Opr Margin | 12.07 | Debt/Equity | 0.02 | |||||
| 2025 | ₹848M | -68.5% (-69.6%) | PreTax Margin | 11.59 | BV/Share | 119 | |||||
| 5Y Average FCF | ₹2B | 3.5% (-21.0%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 7.00% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (3.5%) | ||||||||||
| 2026 | ₹1B | MBG Intrinsic Value | ₹168 | ||||||||
| 2027 | ₹1B | ||||||||||
| 2028 | ₹1B | ||||||||||
| 2029 | ₹1B | ||||||||||
| 2030 | ₹1B | ||||||||||
| 2031 | ₹1B | ||||||||||
| Terminal Value | ₹32B | Net Worth/Share | ₹137 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹28B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹6B | ₹123 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹898M | WACC | 6.5% | 116 | 125 | 136 | 149 | 167 | |||
| Equity Value | ₹33B | 7.1% | 106 | 112 | 120 | 129 | 142 | ||||
| Shares Outstanding | 268,650,163 | 7.8% | 97 | 102 | 108 | 115 | 124 | ||||
| 8.4% | 90 | 94 | 98 | 104 | 111 | ||||||
| DCF Intrinsic Value | ₹123 | 9.0% | 84 | 87 | 91 | 95 | 100 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||